IDAI
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. Current ratio 7.85 · operating margin -244% — readings disagree
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 20 927 titres (~60 155,19 $ US)
- Insiders
- Genner Gareth NevillePotts Charles Edward
- Total bought
-
$60,155
Avg buy (VWAP, 90d window) $2.97 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-08-24
- Last synced
-
2026-08-30 10:16:45
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-24 | Genner Gareth Neville | Buy | 2,000 | $3.21 | $6,420 | Form 4 |
| 2026-08-21 | Genner Gareth Neville | Buy | 1,000 | $3.21 | $3,210 | Form 4 |
| 2026-08-20 | Francis Andrew Scott | Buy | 1,600 | $3.10 | $4,960 | Form 4 |
| 2026-08-20 | Potts Charles Edward | Buy | 627 | $3.19 | $2,000 | Form 4 |
| 2026-08-20 | Genner Gareth Neville | Buy | 800 | $3.09 | $2,472 | Form 4 |
| 2026-08-19 | Genner Gareth Neville | Buy | 606 | $2.55 | $1,545 | Form 4 |
| 2026-08-18 | Genner Gareth Neville | Buy | 2,000 | $2.52 | $5,040 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-08-21
IDAI presents a genuine short-term catalyst — 22% H1 revenue growth, EU IPCEI program selection, Sovereign-AI market entry, and post-news insider buying — yielding a solid event-driven signal (effective catalyst score…
The first sentence of the analysis written for IDAI on 2026-08-21 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 55.9% | 65.4% | 80.0% | 66.8% | 68.7% | |
| Ebit Margin | -252.6% | -327.3% | -172.3% | -224.0% | -245.2% | |
| Ebitda Margin | -228.2% | -303.6% | -167.2% | -204.9% | -229.6% | |
| Operating Profit Margin | -244.0% | -303.9% | -173.0% | -224.3% | -241.7% | |
| Pretax Profit Margin | -259.7% | -343.8% | -167.8% | -224.1% | -246.3% | |
| Continuous Operations Profit Margin | -260.1% | -344.1% | -167.5% | -224.5% | -246.3% | |
| Net Profit Margin | -265.2% | -344.1% | -167.5% | -224.5% | -246.3% | |
| Bottom Line Profit Margin | -265.2% | -407.0% | -167.5% | -224.5% | -246.3% | |
| Current Ratio | 7.848 | 1.120 | 1.731 | 0.646 | 2.402 | |
| Quick Ratio | 7.848 | 1.120 | 1.731 | 0.646 | 2.402 | |
| Solvency Ratio | -3.216 | -1.825 | -1.861 | -1.912 | -2.336 | |
| Cash Ratio | 6.342 | 0.668 | 1.157 | 0.282 | 1.448 | |
| Price To Earnings Ratio | -1.464 | -1.166 | -1.279 | -0.939 | -8.319 | |
| Price To Earnings Growth Ratio | 0.019 | 0.040 | 0.022 | -0.150 | 0.178 | |
| Forward Price To Earnings Growth Ratio | 0.019 | 0.040 | 0.022 | -0.150 | 0.178 | |
| Price To Earnings Diluted Ratio | -1.464 | -1.166 | -1.279 | -0.939 | -8.319 | |
| Price To Earnings Diluted Growth Ratio | 0.019 | 0.040 | 0.022 | -0.150 | 0.178 | |
| Price To Book Ratio | 1.395 | 4.833 | 2.602 | 24.495 | 15.465 | |
| Price To Sales Ratio | 3.876 | 4.747 | 2.141 | 2.109 | 20.487 | |
| Price To Free Cash Flow Ratio | -2.123 | -1.504 | -1.131 | -1.552 | -10.086 | |
| Price To Operating Cash Flow Ratio | -2.141 | -1.640 | -1.244 | -1.792 | -11.242 | |
| Debt To Assets Ratio | 0.107 | 0.480 | 0.138 | 0.214 | 0.099 | |
| Debt To Equity Ratio | 0.138 | 1.365 | 0.290 | 2.964 | 0.176 | |
| Debt To Capital Ratio | 0.121 | 0.577 | 0.225 | 0.748 | 0.149 | |
| Long Term Debt To Capital Ratio | 0.116 | 0.239 | 0.203 | 0.657 | 0.149 | |
| Financial Leverage Ratio | 1.288 | 2.841 | 2.103 | 13.828 | 1.778 | |
| Working Capital Turnover Ratio | 0.894 | 2.481 | 22.217 | 6.013 | 2.454 | |
| Operating Cash Flow Ratio | -5.969 | -2.141 | -2.893 | -1.425 | -2.793 | |
| Operating Cash Flow Sales Ratio | -1.811 | -2.894 | -1.722 | -1.177 | -1.822 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.008 | 1.090 | 1.099 | 1.155 | 1.115 | |
| Debt Service Coverage Ratio | -35.324 | -2.626 | -103.895 | -36.185 | -211.288 | |
| Interest Coverage Ratio | -52.357 | -18.375 | -107.677 | -1,358.709 | -222.442 | |
| Short Term Operating Cash Flow Coverage Ratio | -99.945 | -2.918 | 0.000 | -21.363 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -4.726 | -2.159 | -7.212 | -4.611 | -7.827 | |
| Capital Expenditure Coverage Ratio | -123.405 | -11.057 | -10.080 | -6.456 | -8.723 | |
| Dividend Paid And Capex Coverage Ratio | -123.405 | -11.057 | -10.080 | -6.456 | -8.723 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -1.023 | -1.708 | -1.011 | -1.040 | -8.612 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 55.9% | ▼-9.5% | ▼-11.5% |
| Ebit Margin | -252.6% | ▲74.7% | ▼-8.3% |
| Ebitda Margin | -228.2% | ▲75.4% | ▼-1.5% |
| Operating Profit Margin | -244.0% | ▲59.9% | ▼-6.6% |
| Pretax Profit Margin | -259.7% | ▲84.1% | ▼-11.3% |
| Continuous Operations Profit Margin | -260.1% | ▲84.0% | ▼-11.6% |
| Net Profit Margin | -265.2% | ▲78.9% | ▼-15.7% |
| Bottom Line Profit Margin | -265.2% | ▲141.8% | ▼-3.1% |
| Current Ratio | 7.848 | ▲6.728 | ▲5.099 |
| Quick Ratio | 7.848 | ▲6.728 | ▲5.099 |
| Solvency Ratio | -3.216 | ▼-1.391 | ▼-0.986 |
| Cash Ratio | 6.343 | ▲5.674 | ▲4.363 |
| Price To Earnings Ratio | -1.464 | ▼-0.298 | ▲1.169 |
| Price To Earnings Growth Ratio | 0.019 | ▼-0.021 | ▼-0.003 |
| Forward Price To Earnings Growth Ratio | 0.019 | ▼-0.021 | ▼-0.003 |
| Price To Earnings Diluted Ratio | -1.464 | ▼-0.298 | ▲1.169 |
| Price To Earnings Diluted Growth Ratio | 0.019 | ▼-0.021 | ▼-0.003 |
| Price To Book Ratio | 1.395 | ▼-3.438 | ▼-8.363 |
| Price To Sales Ratio | 3.876 | ▼-0.870 | ▼-2.796 |
| Price To Free Cash Flow Ratio | -2.123 | ▼-0.619 | ▲1.156 |
| Price To Operating Cash Flow Ratio | -2.141 | ▼-0.500 | ▲1.471 |
| Debt To Assets Ratio | 0.107 | ▼-0.373 | ▼-0.101 |
| Debt To Equity Ratio | 0.138 | ▼-1.227 | ▼-0.849 |
| Debt To Capital Ratio | 0.121 | ▼-0.456 | ▼-0.243 |
| Long Term Debt To Capital Ratio | 0.116 | ▼-0.123 | ▼-0.157 |
| Financial Leverage Ratio | 1.288 | ▼-1.553 | ▼-3.080 |
| Working Capital Turnover Ratio | 0.894 | ▼-1.587 | ▼-5.918 |
| Operating Cash Flow Ratio | -5.969 | ▼-3.828 | ▼-2.925 |
| Operating Cash Flow Sales Ratio | -1.811 | ▲1.083 | ▲0.074 |
| Free Cash Flow Operating Cash Flow Ratio | 1.008 | ▼-0.082 | ▼-0.085 |
| Debt Service Coverage Ratio | -35.324 | ▼-32.698 | ▲42.540 |
| Interest Coverage Ratio | -52.357 | ▼-33.982 | ▲299.555 |
| Short Term Operating Cash Flow Coverage Ratio | -99.945 | ▼-97.026 | ▼-75.100 |
| Operating Cash Flow Coverage Ratio | -4.726 | ▼-2.567 | ▲0.581 |
| Capital Expenditure Coverage Ratio | -123.405 | ▼-112.348 | ▼-91.461 |
| Dividend Paid And Capex Coverage Ratio | -123.405 | ▼-112.348 | ▼-91.461 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -1.023 | ▲0.684 | ▲1.655 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $12.2M | $14.6M | $9.8M | $11.4M | $75.3M | |
| Enterprise value | $7.3M | $16.0M | $7.7M | $11.5M | $72.7M | |
| EV / Sales | 2.33x | 5.18x | 1.69x | 2.13x | 19.77x | |
| EV / Op. cash flow | -1.29x | -1.79x | -0.98x | -1.81x | -10.85x | |
| EV / Free cash flow | -1.28x | -1.64x | -0.89x | -1.57x | -9.74x | |
| EV / EBITDA | -1.02x | -1.71x | -1.01x | -1.04x | -8.61x | |
| Net debt / EBITDA | 0.68x | -0.14x | 0.27x | -0.01x | 0.31x | |
| Current ratio | 7.85x | 1.12x | 1.73x | 0.65x | 2.40x | |
| Income quality | 0.68x | 0.84x | 1.03x | 0.52x | 0.74x | |
| Graham net-net | $1 | -$1 | $0 | -$11 | $4 | |
| Tax burden | 102.1% | 100.1% | 99.8% | 100.2% | 100.0% | |
| Interest burden | 102.8% | 105.1% | 97.4% | 100.1% | 100.4% | |
| Working capital | $6.5M | $501K | $2.0M | -$1.6M | $3.4M | |
| Invested capital | $8.1M | $3.7M | $5.1M | $2.0M | $6.1M | |
| Return on assets | -74.1% | -123.3% | -96.8% | -188.6% | -104.5% | |
| Operating ROA | -77.2% | -113.6% | -110.3% | -160.2% | -131.9% | |
| Return on tangible assets | -84.9% | -148.6% | -154.3% | -246.2% | -125.5% | |
| Return on equity | -95.4% | -350.3% | -203.5% | -2607.6% | -185.9% | |
| Return on invested capital | -74.1% | -123.7% | -149.7% | -534.2% | -141.9% | |
| Return on capital employed | -74.5% | -211.3% | -152.3% | -614.9% | -141.9% | |
| Earnings yield | -68.4% | -72.5% | -78.2% | -106.5% | -12.0% | |
| Free cash flow yield | -47.1% | -66.5% | -88.4% | -64.4% | -9.9% | |
| Capex / Op. cash flow | -0.8% | -9.0% | -9.9% | -15.5% | -11.5% | |
| Capex / Depreciation | 6.0% | 110.5% | 98.7% | 129.1% | 133.9% | |
| Capex / Sales | 1.5% | 26.2% | 17.1% | 18.2% | 20.9% | |
| SG&A / Sales | 206.2% | 276.2% | 183.8% | 231.1% | 226.1% | |
| R&D / Sales | 69.2% | 69.4% | 63.8% | 45.9% | 68.8% | |
| Stock comp / Sales | 30.9% | 42.7% | 16.7% | 44.6% | 75.6% | |
| Intangibles / Total assets | 12.7% | 17.0% | 37.3% | 23.4% | 16.7% | |
| Days sales outstanding | 115d | 171d | 105d | 91d | 142d | |
| Days payables outstanding | 39d | 102d | 492d | 193d | 96d | |
| Operating cycle | 115d | 171d | 105d | 91d | 142d | |
| Cash conversion cycle | 77d | 69d | -387d | -103d | 46d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-16.8%EV / Sales ▼-55.0%EV / EBITDA ▲+40.1%EV / Op. cash flow ▲+0.502Earnings yield ▲+0.041
Profitability
Return on equity ▲+2.549Return on assets ▲+0.492Return on invested capital ▲+0.496Return on capital employed ▲+1.368Operating ROA ▲+0.364Income quality ▼-0.158Tax burden ▲+0.020
Efficiency
Days sales outstanding ▼-55.421Days payables outstanding ▼-63.441Operating cycle ▼-55.421Cash conversion cycle ▲+8.019Capex / Sales ▼-0.247R&D / Sales ▼-0.002
Balance-sheet strength
Current ratio ▲+6.728Net debt / EBITDA ▲+0.819Working capital ▲+6021323.000Invested capital ▲+4416269.000Intangibles / Total assets ▼-0.043
Change over 5 years
Valuation
Market cap ▼-83.8%EV / Sales ▼-88.2%EV / EBITDA ▲+88.1%EV / Op. cash flow ▲+9.562Earnings yield ▼-0.564
Profitability
Return on equity ▲+0.905Return on assets ▲+0.305Return on invested capital ▲+0.679Return on capital employed ▲+0.674Operating ROA ▲+0.547Income quality ▼-0.057Tax burden ▲+0.021
Efficiency
Days sales outstanding ▼-27.356Days payables outstanding ▼-57.916Operating cycle ▼-27.356Cash conversion cycle ▲+30.559Capex / Sales ▼-0.194R&D / Sales ▲+0.004
Balance-sheet strength
Current ratio ▲+5.447Net debt / EBITDA ▲+0.365Working capital ▲+3158533.000Invested capital ▲+2026714.000Intangibles / Total assets ▼-0.040
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-08-13 Trust Stamp posts 22% revenue growth in H1, expands African telecom work Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) said its revenue for the six-month period ended June 30 increased 22% year-over-year, driven largely by higher revenue from its S&P 500 bank customer and $192,000 billed in the second quarter for work with a multinational telecommunications company operating in Africa. The identity verification reported net recognized revenue of $1.66 million for the six months ended June 30, 2026, up from $1.36 million a year earlier.
- 2026-08-13 Trust Stamp provided a H1 2026 business report including a 22% increase in net recognized revenue with continued customer and pipeline growth, selection for the European Union''s IPCEI program and entry into the $48 billion Sovereign-AI market ATLANTA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) (‘Trust Stamp'' or ‘The Company'') announced that:
- 2026-07-25 Trust Stamp joins EU semiconductor initiative to advance digital identity Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) has strengthened its position in the European technology ecosystem after being selected as a direct participant in the European Union''s Important Project of Common European Interest (IPCEI) semiconductor initiative, a programme designed to develop an integrated and strategically important semiconductor value chain across Europe. Speaking with Proactive, Executive Director and Project Lead Berta Pappenheim described the selection as a significant endorsement of the company''s expertise in identity and data security.
- 2026-07-25 Trust Stamp joins EU semiconductor initiative to advance digital identity Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) has strengthened its position in the European technology ecosystem after being selected as a direct participant in...
- 2026-07-15 Trust Stamp announces that it will be holding a shareholder update call on July 17th, 2026 ATLANTA, GA, July 15, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), announces that it will host a shareholder conference call on Friday, July 17, 2026, at 12:00 p.m. Eastern Time to discuss recent business developments including the Company''s growing focus on Sovereign-AI and other associated sovereign technologies.
- 2026-07-07 Trust Stamp subsidiary joins EU semiconductor initiative Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) said its Maltese subsidiary will participate directly in the EU''s Important Project of Common European Interest on Advanced Semiconductor Technologies (IPCEI AST). Trust Stamp Malta Limited joins the coordinated European initiative aimed at strengthening the continent''s sovereignty, security and resilience across the advanced semiconductor value chain.
- 2026-07-07 Trust Stamp subsidiary joins EU semiconductor initiative Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) said its Maltese subsidiary will participate directly in the EU’s Important Project of Common European Interest on...
- 2026-07-07 Trust Stamp joins the European Union Semiconductor Initiative (IPCEI AST) with the Support of Malta Enterprise ATLANTA, GA, July 07, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), today announced that its Maltese subsidiary, Trust Stamp Malta Limited, has been selected as a direct participant in the Important Project of Common European Interest on Advanced Semiconductor Technologies (IPCEI AST), with the support of Malta Enterprise. The IPCEI AST is a major, coordinated European initiative backed by participating EU Member States and their national authorities, with the objective of strengthening Europe''s sovereignty, security and resilience across the advanced semiconductor value chain.
- 2026-07-02 Trust Stamp files provisional patent for AI-powered medical diagnostic support system Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) has filed a US provisional patent application for an artificial intelligence-based medical diagnostic support system aimed at helping physicians evaluate diagnoses while addressing common limitations of large language models (LLMs). The patent application, titled "Medical Diagnostic Assurance System" (MDAS), was filed on June 15, 2026.
- 2026-07-02 Trust Stamp makes first LLM-focused AI Patent filing for Medical Diagnosis Assurance Atlanta, GA, July 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) Gareth N. Genner, Chief Executive Officer of the Company commented, “Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography.